Literature DB >> 29264635

Fat necrosis after abdominal surgery: A pitfall in interpretation of FDG-PET/CT.

Tima Davidson1,2, Eyal Lotan3,4, Eyal Klang3,4, Johnatan Nissan5, Jeffrey Goldstein6, Elinor Goshen7,3, Simona Ben-Haim7,8, Sara Apter3,4, Bar Chikman9.   

Abstract

OBJECTIVE: We describe FDG-PET/CT findings of postoperative fat necrosis in patients following abdominal surgery, and evaluate their changes in size and FDG uptake over time.
METHODS: FDG-PET/CT scans from January 2007-January 2016 containing the term 'fat necrosis' were reviewed. Lesions meeting radiological criteria of fat necrosis in patients with prior abdominal surgery were included.
RESULTS: Forty-four patients, 30 males, mean age 68.4 ± 11.0 years. Surgeries: laparotomy (n=37; 84.1 %), laparoscopy (n=3; 6.8 %), unknown (n=4; 9.1 %). CTs of all lesions included hyperdense well-defined rims surrounding a heterogeneous fatty core. Sites: peritoneum (n=34; 77 %), omental fat (n=19; 43 %), subcutaneous fat (n=8; 18 %), retroperitoneum (n=2; 5 %). Mean lesion long axis: 33.6±24.9 mm (range: 13.0-140.0). Mean SUVmax: 2.6±1.1 (range: 0.6-5.1). On serial CTs (n=34), lesions decreased in size (p=0.022). Serial FDG-PET/CT (n=24) showed no significant change in FDG-avidity (p=0.110). Mean SUVmax did not correlate with time from surgery (p=0.558) or lesion size (p=0.259).
CONCLUSION: Postsurgical fat necrosis demonstrated characteristic CT features and may demonstrate increased FDG uptake. However, follow-up of subsequent imaging scans showed no increases in size or FDG-avidity. Awareness of this entity is important to avoid misinterpretation of findings as recurrent cancer. KEY POINTS: • Postsurgical fat necrosis may mimic cancer in FDG-PET/CT. • Follow-up of fat necrosis showed no increase in FDG intensity. • CT follow-up showed a decrease in lesion size. • FDG uptake did not correlate with time lapsed from surgery.

Entities:  

Keywords:  Abdominal; FDG PET-CT; Fat necrosis; Pitfall; Postoperative

Mesh:

Substances:

Year:  2017        PMID: 29264635     DOI: 10.1007/s00330-017-5201-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Fat necrosis in the abdomen after surgery close to the pancreas: Potential false-positive on positron emission tomography.

Authors:  Madhusudhan P Reddy; Guillermo Sangster; Maureen G Heldmann; David L Lilien
Journal:  Clin Nucl Med       Date:  2006-08       Impact factor: 7.794

2.  High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.

Authors:  Raghava Kashyap; Eddie Lau; Anupkumar George; John F Seymour; Stephen Lade; Rodney J Hicks; Michael S Hofman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

3.  Fat necrosis may mimic local recurrence of breast cancer in FDG PET/CT.

Authors:  Burcu E Akkas; G Ucmak Vural
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2012-08-04       Impact factor: 1.359

4.  Postoperative changes after surgical mesh hernia repair: a pitfall in interpretation of 18F-FDG PET-CT.

Authors:  T Davidson; E Klang; E Goshen; J Goldstein; M Khaikin; B Chikman; S Ben-Haim
Journal:  Hernia       Date:  2017-04-06       Impact factor: 4.739

5.  Encapsulated Fat Necrosis Mimicking an Intra-abdominal Tumor.

Authors:  Alberto Biondi; Valeria Fico; Angelo A Marra; Roberto Persiani
Journal:  J Gastrointest Surg       Date:  2016-09-09       Impact factor: 3.452

6.  PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.

Authors:  E Goshen; T Davidson; D Aderka; S T Zwas
Journal:  Br J Radiol       Date:  2006-07       Impact factor: 3.039

7.  Imaging manifestations of abdominal fat necrosis and its mimics.

Authors:  Aya Kamaya; Michael P Federle; Terry S Desser
Journal:  Radiographics       Date:  2011 Nov-Dec       Impact factor: 5.333

8.  ¹⁸F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study.

Authors:  H Balink; S S Tan; N J G M Veeger; F Holleman; B L F van Eck-Smit; R J Bennink; H J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-06       Impact factor: 9.236

9.  The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults.

Authors:  Ching-Jung Hsieh; Pei-Wen Wang; Tse-Ying Chen
Journal:  Diabetol Metab Syndr       Date:  2014-04-01       Impact factor: 3.320

10.  Subcutaneous encapsulated fat necrosis.

Authors:  Dogu Aydin; Jais O Berg
Journal:  Clin Case Rep       Date:  2016-03-10
View more
  5 in total

1.  Physiologic and hypermetabolic breast 18-F FDG uptake on PET/CT during lactation.

Authors:  Noam Nissan; Israel Sandler; Michal Eifer; Yael Eshet; Tima Davidson; Hanna Bernstine; David Groshar; Miri Sklair-Levy; Liran Domachevsky
Journal:  Eur Radiol       Date:  2020-08-04       Impact factor: 5.315

2.  18F-FDG PET-CT postoperative changes after maxillectomy: Findings and pitfalls in interpretation.

Authors:  Tima Davidson; Johnatan Nissan; Maria Krichmar; Eyal Lotan; Shai Shrot; Iris Gluck; Paul Lawson; Ran Yahalom; Shay Duvdevani
Journal:  Dentomaxillofac Radiol       Date:  2021-04-29       Impact factor: 3.525

3.  The utility of PET/CT in large vessel vasculitis.

Authors:  Jennifer Ben Shimol; Howard Amital; Merav Lidar; Liran Domachevsky; Yehuda Shoenfeld; Tima Davidson
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

4.  The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical Center.

Authors:  Hussein Mahajna; Keren Vaknin; Jennifer Ben Shimol; Abdulla Watad; Arsalan Abu-Much; Naim Mahroum; Ora Shovman; Yehuda Shoenfeld; Howard Amital; Tima Davidson
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

5.  Penile secondary lesions: a rare entity detected by PET/CT.

Authors:  Tima Davidson; Liran Domachevsky; Yogev Giladi; Eddie Fridman; Zohar Dotan; Barak Rosenzweig; Raya Leibowitz; Jennifer Ben Shimol
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.